Quantcast

Latest Tapentadol Stories

2012-06-07 12:00:33

A new Phase III study presented today at EULAR 2012, the Annual Congress of the European League Against Rheumatism, shows that patients treated with certolizumab pegol (CZP) were twice as likely to meet the primary endpoint of ACR20 response at week 12 than those on placebo: 58% on CZP200mg Q2W; and 51.9% on CZP 400 mg Q4W compared to 24.3% on placebo.


Word of the Day
ethnarch
  • The governor of a province or people.
The word 'ethnarch' comes from a Greek word meaning 'ruler of a tribe or nation'.
Related